Navigation Links
Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
Date:7/30/2008

of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, infectious disease, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1) "Income, Poverty, and Health Insurance Coverage in the United States: 2006." U.S. C
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
2. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
3. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
4. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
6. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
7. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
10. Dr. Web Makes Many Americans Question Trusted Health Providers
11. BCBSNC Makes Electronic Prescribing Available Statewide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...w York City Mayor Michael R. Bloomberg declared Ja...ented a proclamation to Ilchi Lee, president of IB...d developer of Brain Education, a revolutionary me...-being, and mental ability for all ages. Lee is a ...ower of individuals to change themselves and the w...
(Date:1/8/2009)...risk may not be accurate in some cases , ...s, from the United States and the Netherlands, que...ed Framingham Risk Score in predicting heart disea...core, based on findings of a decades-long study in...ssess risk on the basis of seven factors: age, gen...
(Date:1/8/2009)...-USNewswire/ -- Today, the National Hospice and Pa...onal leadership organizations issued a consensus s...and protection of the Medicare Hospice Benefit. Th...unified message about end-of-life care are the Ame...ne, Hospice and Palliative Nurses Association, Nat...
(Date:1/8/2009)...izations offers five action steps to improve respo...re/ -- Despite the recent three-hour cease fires t...to residents of the Palestinian territory, upwards...n water and medical help. U.S.-based international...ion see this arrangement to allow sporadic deliver...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3
...ent findings that the widely-used herbal supplemen...bsorption and metabolism of many prescription and... popular herbal supplements might cause similar ch...rugs therapeutic or toxic effects. What, for exam...
...nagers who watch television several hours a day ma...dy that claims to be the first one to link increa...ies have also connected television to poor academi...tudy, Jeffrey Johnson of the New York State Psychi...
... proportion of newborns screened for hearing loss ...itting 95% by mid-2006.But a third of them do not ...ceptible to delays in language development that t...te, director of the National Center for Hearing As...
...earchers will present study results that indicate ...es degenerative and inflammatory responses in dia...in Vision and Ophthalmology (ARVO) 2007 Annual Mee...ll take place on Thursday, May 10 from 10:45 a.m. ...
Other Medicine News:Health News:Recommended Doses of Herbal Supplement Do Not Interfere With Drug Absorption 2Health News:Too Much TV Watching Linked With Poor Academic Performance in Teens 2Health News:Experts Stress Need for Follow-up Evaluation of Children Who Fail Hearing Loss Screening 2
(Date:1/8/2009)... initial dose in an ongoing Phase Ib trial demonst...three days , , Conference Call Today at 8:30AM ...l/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...f an ongoing Phase Ib clinical trial of ANA598, th...ase inhibitor. ANA598 was very well-tolerated and...
(Date:1/7/2009)...ts in Development Based On Osteotech,s Proprietary...oRegeneration; FDA Filing Anticipated in Third Qua...ire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OST...oducts for regenerative healing, announced today t...its DuraTech(TM) BioRegeneration Matrix. The first...
(Date:1/6/2009)...PRNewswire/ -- In recent controlled studies conduc... , scientists found that the patented ingredient i...ly proven ingredient to increase levels of nitric ...itrate/nitrate (NOx) in human subjects. , , Nit...rease in blood flow to the skeletal muscles. This...
(Date:1/6/2009)...ary 6 , - Early R...n Until,December 2011 , - Expansion of the...iscovery in Ophthalmology , - Revised Comme...ublicenses to a Third Party , ExonHit The...nforcement,of its existing drug discovery collabo...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 1Linkwell Corp to File to Extend Filing Date for 2007 Form 10 K 15566 2National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R Kerry Clark 15563 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 1Dynatronics Introduces New Synergie Elite Aesthetic Line 15560 2Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 1Medical Mutual of Ohio Earns Top Accreditation for Product Excellence 15557 2
...03, 2007 /PRNewswire-FirstCall/ --,Phosphagenics L...,intends to initiate a Phase 1b clinical trial to ...d formulation of its transdermal,insulin product, ...e trial is expected to commence in the second quar...ed as a novel "needle-free",way of administering i...
... WIRE)--May 3, 2007 - Xanthus,Pharmaceuticals, Inc...M) reversed the clinical and pathological signs of...clerosis. The presentation,was made by Stephen J. ...t the University of Western Ontario, London, Ontar...ster session at the,59th American Academy of Neuro...
Other Medicine Technology:Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical,Trial in Second Quarter 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3
...Single Head Rectangular Camera ,IS2s Single ...ole body scans and SPECT studies. Offering flexibi...ingle Rectangular Head Camera is an ideal camera f...purpose work, and also acquires excellent cardiac ...
...Arctic Circler uses the same cryoconsole and platf...in the pulmonary veins. Arctic Circler is an ablat...liative-only treatments that rely on medication.,...catheter has the ability to create curvilinear les...
...Aneurysm occlusion is the ultimate objective of ne...num coils. With Matrix Detachable Coils, occlusion...ls are intended for embolization of those intracra..., their location, or the patient's general medical...
Tungsten Carbide wire twister.
Medicine Products: